New VP of Scientific Operations and VP of Scientific Consulting

XenoTech has appointed Joanna Barbara, Ph.D., as Vice President of Scientific Operations and Brian Ogilvie, Ph.D., as Vice President of Scientific Consulting. They share a combined 30 years of experience with the company and are respected experts in their fields.

As Vice President of Scientific Operations, Dr. Joanna Barbara is responsible for the development, design, operation, and improvement of XenoTech’s Scientific Division. Joanna joined the company in 2007. In that time, she has served in Mass Spectrometry Specialist roles, as the Division Director of Analytical Services and Division Director of Scientific Operations at XenoTech. Dr. Barbara also serves as an Adjunct Graduate Professor of Pharmaceutical Sciences for the College of Pharmacy at the University of Missouri – Kansas City. She has authored or coauthored numerous scientific posters and papers, and has represented XenoTech as an invited speaker at various analytical and drug metabolism conferences. Joanna is quality-oriented with extensive experience in DM2PK, regulatory compliance and process and project management.

Dr. Brian Ogilvie joined XenoTech in 1997. From 1999 to 2006, he was the head of the CYP Inhibition Department. Brian became a member of the XenoTech Consulting Department in 2006 and participates in drug-drug interaction-related R&D projects, authors various publications, and writes expert opinions for consulting clients. As Vice President of Scientific Consulting, Dr. Ogilvie is additionally involved in quality management and strategic planning for the company in scientifically relevant areas. Brian is an author or coauthor on over 50 scientific posters, peer-reviewed publications or book chapters on the topics of drug metabolism, transport and drug-drug interactions, and has represented the company as an invited speaker at various drug metabolism conferences.